Belachwe Yohanes Abera, Sento Midekso, Gobena Melese Negash, Getahun Mihiret Shawel, Negussie Yohannes Mekuria
Department of Public Health, Adama General Hospital and Medical College, Adama, Ethiopia.
Department of Biomedical Sciences, Adama Hospital Medical College, Adama, Ethiopia.
Front Glob Womens Health. 2025 Apr 1;6:1510299. doi: 10.3389/fgwh.2025.1510299. eCollection 2025.
The World Health Organization advocates dual contraceptive methods for women with Human Immunodeficiency Virus (HIV) to prevent unintended pregnancies and sexually transmitted infections (STIs), enhancing education, economic opportunities, and maternal-child health outcomes. However, persistent global challenges stem from inadequate use of dual contraceptives and unsafe sexual practices, resulting in high rates of unintended pregnancies and significant health risks. Hence, this study aimed to assess dual contraceptive use among women living with HIV on anti-retroviral therapy (ART) in Boset District, Ethiopia.
A facility-based cross-sectional study was conducted among 342 women living with HIV from September 12 to October 18, 2023. Participants were selected by systematic random sampling, and data were collected using an interviewer-administered structured questionnaire. The collected data were entered using Epi Info version 7.2.6 and analyzed using SPSS version 26.0. Bivariable and multivariable binary logistic regression analyses were performed to assess the association between the outcome and explanatory variables. In the multivariable analysis, an adjusted odds ratio (AOR) with a 95% confidence interval (CI) was used to show the strength of the association, and the level of significance was set at a -value of <0.05.
The magnitude of dual contraceptive use was 33.7% (95% CI: 28-40). Urban residence (AOR = 2.5; 95% CI: 1.97-8.08), good knowledge about dual contraceptives (AOR = 3.8; 95% CI: 2.36-8.67), STIs history in the past 12 months (AOR = 2.6, 95% CI: 1.25-4.72) and having two or more number of sexual partners, (AOR = 1.9; 95% CI: 1.18-6.68), were factors significantly associated with dual contraceptive use.
One-third of women living with HIV on ART utilized dual contraceptives. Place of residence, knowledge about dual contraceptives, history of STIs in the past 12 months, and number of sexual partners were factors associated with dual contraceptive use. It is essential to implement focused educational programs to increase knowledge about dual contraceptives, alongside expanding access to contraceptive services in rural and underserved areas.
世界卫生组织提倡为感染人类免疫缺陷病毒（HIV）的女性采用双重避孕方法，以预防意外怀孕和性传播感染（STIs），改善教育、增加经济机会并提升母婴健康水平。然而，全球持续面临挑战，双重避孕措施使用不足以及不安全的性行为导致意外怀孕率居高不下，并带来重大健康风险。因此，本研究旨在评估埃塞俄比亚博塞特区接受抗逆转录病毒治疗（ART）的HIV感染女性的双重避孕措施使用情况。
2023年9月12日至10月18日，在342名HIV感染女性中开展了一项基于医疗机构的横断面研究。通过系统随机抽样选取参与者，并使用访谈员协助填写的结构化问卷收集数据。收集到的数据使用Epi Info 7.2.6版本录入，并使用SPSS 26.0版本进行分析。进行双变量和多变量二元逻辑回归分析，以评估结果变量与解释变量之间的关联。在多变量分析中，使用调整后的比值比（AOR）及95%置信区间（CI）来显示关联强度，显著性水平设定为P值<0.05。
双重避孕措施的使用比例为33.7%（95% CI：28 - 40）。城市居住（AOR = 2.5；95% CI：1.97 - 8.08）、对双重避孕措施有充分了解（AOR = 3.8；95% CI：2.36 - 8.67）、过去12个月内有性传播感染病史（AOR = 2.6，95% CI：1.25 - 4.72）以及有两个或更多性伴侣（AOR = 1.9；95% CI：1.18 - 6.68），均为与双重避孕措施使用显著相关的因素。
接受抗逆转录病毒治疗的HIV感染女性中有三分之一采用了双重避孕措施。居住地点、对双重避孕措施的了解、过去12个月内的性传播感染病史以及性伴侣数量均为与双重避孕措施使用相关的因素。必须实施针对性的教育项目，以增加对双重避孕措施的了解，同时在农村和服务不足地区扩大避孕服务的可及性。
